8点1氪丨周生生再发声明，回应足金挂坠检测出含铁银钯；大润发母公司辟谣CEO被警方带走；极氪8X信息遭提前泄露

Group 1 - Guotou Ruijin Fund announced an adjustment to the valuation method of its silver LOF, leading to a significant drop of over 31% in the net asset value of its silver futures A shares on the same day [8] - The adjustment sparked controversy among investors, particularly regarding the timing of the announcement, which was made after trading hours [8] - The fund stated that prior notice could have led to panic and potential runs on the fund, hence the decision to announce post-trading [8] Group 2 - The stock price of Cambrian Technology plummeted by 12.88%, resulting in a market value loss of nearly 700 billion yuan, marking its largest single-day drop since September 2025 [9] - Cambrian responded to the market concerns by stating it was unaware of the specific reasons for the stock decline and emphasized that its operations were progressing smoothly [9] - Analysts suggested that high valuations and increased competition in the AI chip sector may have contributed to the sell-off [9] Group 3 - Tencent and other internet companies faced a significant drop in stock prices due to rumors of an increase in value-added tax, which were later debunked as false [10] - Tax experts clarified that the current VAT rates for these companies remain unchanged at 6%, alleviating concerns over potential tax hikes [10] Group 4 - Adobe announced it will discontinue its 2D animation software, Adobe Animate, by March 1, 2026, citing advancements in technology and changing user needs as reasons for the decision [11] - The software has been in use for over 25 years and has played a significant role in the animation ecosystem [11] Group 5 - JD.com announced it will invest over 1.3 billion yuan in benefits for frontline employees during the Spring Festival, including bonuses and subsidies [7] - The initiative aims to provide support and a sense of community for employees working during the holiday season [7] Group 6 - Red Star Capital completed the global acquisition of the antibiotic Moxifloxacin, establishing a new biopharmaceutical company focused on infection and respiratory diseases [11] - The acquisition includes essential assets such as drug registration certificates and intellectual property rights [11]